Skip to main content
. 2016 Feb 2;5(4):296–305. doi: 10.1002/cpdd.240

Figure 3.

Figure 3

Change in VEGF (A, C) plasma and (B, D) serum concentrations: 7‐day study—stage 1 and stage 2. Levels of plasma or serum levels of VEGF measured by ELISA on day 1 and day 7 at specified times in subjects dosed daily for 7 days with placebo, 0.3, 0.6, or 1.2 mg/kg twice daily.